Glucometric parameter changes in patients with type 2 diabetes during ramadan fasting: A prospective comparative real-world study

被引:1
|
作者
Al Hayek, Ayman [1 ]
Al Zahrani, Wael M. [1 ]
Al Dawish, Mohamed Abdulaziz [1 ]
机构
[1] Prince Sultan Mil Med City, Diabet Treatment Ctr, Dept Endocrinol & Diabet, Riyadh, Saudi Arabia
来源
METABOLISM OPEN | 2024年 / 23卷
关键词
Type 2 diabetes mellitus; Ramadan fasting; Glucose monitoring; Self-care management; GLYCEMIC CONTROL; GLUCOSE LEVEL; MELLITUS; CARE; ASSOCIATION; PROFILE; IMPACT;
D O I
10.1016/j.metop.2024.100304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study assessed glucometric changes in Type 2 diabetes mellitus (T2DM) patients before, during, and after Ramadan fasting using an intermittently scanned continuous glucose monitoring system (isCGMS). Methods: This prospective comparative study included T2DM patients aged 30-70 years who were receiving nonintensive insulin in Riyadh, Saudi Arabia. In addition to the baseline characteristics, glycated hemoglobin (HbA1c) and ambulatory glucose profile (AGP)-derived metric data were collected at three specific points: pre-, during-, and post-Ramadan. Self-care activities during Ramadan were evaluated using the Diabetes SelfManagement Questionnaire (DSMQ). Results: Overall, a total of 93 T2DM patients were enrolled in the study. Their mean age +/- SD age was 47.9 +/- 7.5 years, and 51.6 % of them were males. Compared with pre- and post-Ramadan, there was a significant decrease in HbA1c (p < 0.001 for both periods), average glucose level (p = 0.001 and p = 0.026, respectively), glucose variability (p = 0.043 and p = 0.005, respectively), and % time above the range of 181-250 mg/dL (p < 0.001 for both periods), as well as a significant increase in % time in target (70-180 mg/dL) during Ramadan (p < 0.001 for both periods). However, the % time below 54 mg/dL was slightly greater during Ramadan than both pre- and post-Ramadan (p <0.001 and p = 0.002, respectively). Furthermore, 32.3 % reported inadequate selfcare behaviors during Ramadan. Conclusions: Ramadan fasting could improve glucose levels in T2DM patients who were not on intensive insulin, with a relatively low incidence of hypoglycemia.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Changes in glycaemic parameters with Ramadan fasting in patients with Type 1 and Type 2 diabetes on insulin: A flash glucose monitoring (FGM) study
    Saadane, I.
    Barakat, M. T.
    Lessan, N.
    DIABETIC MEDICINE, 2019, 36 : 143 - 143
  • [42] Impact of Fasting on Adherence to Dosing Instructions and Efficacy of Oral Semaglutide during Ramadan in People with Type 2 Diabetes in Real-World Setting-O-SEMA-Fast Subanalysis
    Hassanein, Mohamed
    Alkadhim, Ibrahim
    Aly, Hazem
    Bajawi, Dalila
    Cinar, Tarhan
    Dhanwal, Dinesh
    Jabbar, Abdul
    Khader, Said
    Khudadah, Khaled
    Muzaffar, Talal
    Ngome, Mary
    Nafach, Jalal
    Shaghouli, Amna
    DIABETES, 2024, 73
  • [43] Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study
    Uddin, Mohammed Farid
    Khan, Murshed Ahamed
    Selim, Shahjada
    Sultana, Nusrat
    Sayem, Mohammad Abu
    Iftekhar, Mohammed Mahboob
    Bin Habib, Maruf
    Akter, Nazma
    Khan, Shahjamal
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (02)
  • [44] Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study
    Uddin, Mohammed Farid
    Khan, Murshed Ahamed
    Selim, Shahjada
    Sultana, Nusrat
    Abu Sayem, Mohammad
    Iftekhar, Mohammed Mahboob
    Bin Habib, Maruf
    Akter, Nazma
    Khan, Shahjamal
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, : e230132
  • [45] Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting
    Mafauzy, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 58 (01) : 45 - 53
  • [46] Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting
    Yousuf, Sanobia
    Ahmedani, Muhammad Yakoob
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (11)
  • [47] Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
    AlMaatouq, Mohamed A.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 109 - 119
  • [48] Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
    Al Sifri, Saud
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 293 - 294
  • [49] Real life experience of usage of vildagliptin versus sulfonylurea therapy in fasting patients with type 2 diabetes during Ramadan: an Indian experience
    Shete, A. V. V.
    DIABETOLOGIA, 2011, 54 : S342 - S343
  • [50] Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan
    Schweizer, Anja
    Halimi, Serge
    Dejager, Sylvie
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 15 - 24